Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

BACKGROUND: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous immunotherapy (SCIT) and to identify the main causes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World Allergy Organ J
Asıl Yazarlar: Koca Kalkan, Ilkay, Ates, Hale, Aksu, Kurtulus, Yesilkaya, Selma, Topel, Musa, Cuhadar Ercelebi, Dilek, Turkyilmaz, Suleyman, Oncul, Ali, Demir, Senay
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: World Allergy Organization 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8185179/
https://ncbi.nlm.nih.gov/pubmed/34122718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100558
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller